bioAffinity Technologies Inc.
Save
16.59M
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Diagnostics & Research
Industry

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level.

Similar securities

Based on sector and market capitalization

Report issue